| Bioactivity | GRP-60367 is a first-in-class small-molecule rabies virus (RABV) entry inhibitor with nanomolar potency against some RABV strains[1]. |
| Invitro | GRP-60367 inhibits entry of a subset of RABV strains. GRP-60367 shows specific and potent anti-RABV activity of the scaffold, returning in dose-response assays EC50s ranging from 2 to 52 nM on different host cell lines[1]. |
| Name | GRP-60367 |
| CAS | 1309241-34-6 |
| Formula | C21H27N3O2 |
| Molar Mass | 353.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Venice Du Pont, et al. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. J Virol. 2020 Jun 16;94(13):e00321-20. |
GRP-60367
CAS: 1309241-34-6 F: C21H27N3O2 W: 353.46
GRP-60367 is a first-in-class small-molecule rabies virus (RABV) entry inhibitor with nanomolar potency against some RAB
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.